Yani Zhang

Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors

Li Ma, Peng Wang, Siyun Shen, 2022, Advanced science.

Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment

R. Yao, Q. Cheng, Zhixuan Li, 2022, npj Precision Oncology.

Tumor-specific circRNA-derived antigen peptide identification for hepatobiliary tumors

Li Ma, Siyun Shen, Dong Gao, 2022, Engineering.

Comprehensive analysis of spatial architecture in primary liver cancer

Hongyang Wang, Wenbo Guo, Jin Gu, 2021, bioRxiv.

Single‐Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids

R. Wu, Hong-Yang Wang, D. Gao, 2021, Advanced science.

Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy.

Yan Zhao, Yani Zhang, Lei Chen, 2020, Biochimica et biophysica acta. Reviews on cancer.

Discovery of a Carbamoyl Phosphate Synthetase 1–Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis

Hongyang Wang, Jin Gu, Jing Tang, 2021, Hepatology.

The effect of biliary obstruction, biliary drainage and bile reinfusion on bile acid metabolism and gut microbiota in mice

Hongyang Wang, Lei Chen, Bo Zheng, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Integrated Multi-Omics Landscape of Liver Metastases.

G. Cai, Z. Meng, Siyun Shen, 2022, Gastroenterology.

Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.

Siyun Shen, Bo Zheng, Yani Zhang, 2024, Cancer letters.

Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions

Yong Wang, Qiuyue Yuan, Siyun Shen, 2024, Cell reports. Medicine.